Italy
· Delayed Price · Currency is EUR Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of EUR 111.03 billion. The enterprise value is 121.74 billion.
| Market Cap | 111.03B |
| Enterprise Value | 121.74B |
Important Dates
The last earnings date was Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | May 12, 2025 |
Share Statistics
| Current Share Class | 1.22B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.31% |
| Shares Change (QoQ) | -1.57% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 17.63 and the forward PE ratio is 11.03.
| PE Ratio | 17.63 |
| Forward PE | 11.03 |
| PS Ratio | 2.46 |
| PB Ratio | 1.43 |
| P/TBV Ratio | 5.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 19.33 |
| EV / Sales | 2.70 |
| EV / EBITDA | 9.66 |
| EV / EBIT | 12.76 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 1.44 |
| Debt / FCF | n/a |
| Interest Coverage | 17.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 6.23% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 544,970 |
| Profits Per Employee | 76,003 |
| Employee Count | 82,878 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.49% in the last 52 weeks. The beta is 0.43, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -1.49% |
| 50-Day Moving Average | 99.29 |
| 200-Day Moving Average | 98.63 |
| Relative Strength Index (RSI) | 38.23 |
| Average Volume (20 Days) | 1,291 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of EUR 45.17 billion and earned 6.30 billion in profits. Earnings per share was 5.04.
| Revenue | 45.17B |
| Gross Profit | 32.05B |
| Operating Income | 9.39B |
| Pretax Income | 7.87B |
| Net Income | 6.30B |
| EBITDA | 12.15B |
| EBIT | 9.39B |
| Earnings Per Share (EPS) | 5.04 |
Balance Sheet
The company has 7.56 billion in cash and 17.91 billion in debt, giving a net cash position of -10.36 billion.
| Cash & Cash Equivalents | 7.56B |
| Total Debt | 17.91B |
| Net Cash | -10.36B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 77.86B |
| Book Value Per Share | 61.83 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.96%, with operating and profit margins of 20.80% and 13.95%.
| Gross Margin | 70.96% |
| Operating Margin | 20.80% |
| Pretax Margin | 17.41% |
| Profit Margin | 13.95% |
| EBITDA Margin | 26.90% |
| EBIT Margin | 20.80% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.92, which amounts to a dividend yield of 4.22%.
| Dividend Per Share | 3.92 |
| Dividend Yield | 4.22% |
| Dividend Growth (YoY) | 4.26% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.31% |
| Shareholder Yield | 4.53% |
| Earnings Yield | 5.67% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |